Примери за използване на Patients should be observed на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Patients should be observed closely for signs of toxicity.
Although fainting episodes are uncommon, patients should be observed for15 minutes after they receive the HPV vaccine.
Patients should be observed and given supportive treatment.
Although fainting episodes are uncommon, patients should be observed for 15 minutes after they receive HPV vaccine.
Patients should be observed closely for hypersensitivity reactions.
Elderly or cachectic patients should be observed carefully and the dose reduced if necessary.
Patients should be observed closely for possible liver abnormalities.
If the combination is used, patients should be observed for signs and symptoms of heart failure, weight gain and oedema.
Patients should be observed closely during the initial cycles of treatment.
If the combination is used, patients should be observed for signs and symptoms of heart failure, weight gain and oedema.
Patients should be observed for at least 20 minutes following allergenic extract injections.
If the combination is used, patients should be observed for signs and symptoms of heart failure, weight gain and oedema.
Patients should be observed carefully after being given the medicine.
Elderly, cachectic, or debilitated patients should be observed carefully for signs of fentanyl toxicity and the dose reduced if necessary.
Patients should be observed for any signs of an injection site reaction.
Therefore patients should be observed for evidence of glucose intolerance.
Patients should be observed by the physician for immediate toxic reactions.
All other patients should be observed for at least 20 minutes after administration.
Patients should be observed for at least 30 minutes following each infusion.
All other patients should be observed for at least 20 minutes after administration.
Patients should be observed during the infusion and for at least 30 minutes after infusion.
All other patients should be observed for at least 20 minutes after the administration.
Patients should be observed for signs of shortness of breath for one hour after each dose.
All patients should be observed continuously during each infusion.
These patients should be observed carefully for signs and symptoms of thromboembolism.
Patients should be observed for at least 15 minutes following MabThera subcutaneous administration.
Patients should be observed during the first hour after each dose for signs and symptoms of bronchospasm.
Patients should be observed for signs and symptoms of heart failure, weight gain or oedema;
Patients should be observed closely for infusion-related reactions, especially during the first infusion.
Patients should be observed for allergic reactions for 30 minutes after the injection of each implant.